Related references
Note: Only part of the references are listed.Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
Penny Whiting et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Cystic fibrosis: An inherited disease affecting mucin-producing organs
Camille Ehre et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis
Mark J. Hoegger et al.
SCIENCE (2014)
CFTR Potentiators: Not an Open and Shut Case
John P. Clancy
SCIENCE TRANSLATIONAL MEDICINE (2014)
Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression
Guido Veit et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis
Deborah M. Cholon et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Elton Kerem et al.
LANCET RESPIRATORY MEDICINE (2014)
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
Michael P. Boyle et al.
LANCET RESPIRATORY MEDICINE (2014)
Searching for Combinations of Small-Molecule Correctors to Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
Clement Boinot et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Lung Clearance Index as an Outcome Measure for Clinical Trials in Young Children with Cystic Fibrosis A Pilot Study Using Inhaled Hypertonic Saline
Padmaja Subbarao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Jane C. Davies et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Cystic Fibrosis: CFTR Modulators and their Mechanism of Action
Erika Nieddu
CURRENT PHARMACEUTICAL DESIGN (2013)
Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs
David A. Stoltz et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Normal mucus formation requires cAMP-dependent HCO3- secretion and Ca2+-mediated mucin exocytosis
Ning Yang et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways
M. Kesimer et al.
MUCOSAL IMMUNOLOGY (2013)
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Johanna F. Dekkers et al.
NATURE MEDICINE (2013)
Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications
Malena Cohen-Cymberknoh et al.
THORAX (2013)
Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
Patrick A. Flume et al.
CHEST (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
CFTR: folding, misfolding and correcting the ΔF508 conformational defect
Gergely L. Lukacs et al.
TRENDS IN MOLECULAR MEDICINE (2012)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of epithelial HCO3- transport in mucin secretion: lessons from cystic fibrosis
Paul M. Quinton
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Produces Abnormalities in Tracheal Development in Neonatal Pigs and Young Children
David K. Meyerholz et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Functional Stability of Rescued ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells
Asta Jurkuvenaite et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia
Jeng-Haur Chen et al.
CELL (2010)
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
Frank J. Accurso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases Progress in Development
Steven M. Rowe et al.
BIODRUGS (2009)
BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTRΔF508 via the Derlin-1 complex
Bing Wang et al.
CELL (2008)
Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis
Paul M. Quinton
LANCET (2008)
Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis
Jae Young Choi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inflammation and anti-inflammatory therapies for cystic fibrosis
James F. Chmiel et al.
CLINICS IN CHEST MEDICINE (2007)
A novel host defense system of airways is defective in cystic fibrosis
Patryk Moskwa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Evidence for airway surface dehydration as the initiating event in CF airway disease
R. C. Boucher
JOURNAL OF INTERNAL MEDICINE (2007)
Acinar origin of CFTR-dependent airway submucosal gland fluid secretion
Jin V. Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands
NS Joo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mucus clearance and lung function in cystic fibrosis with hypertonic saline
SH Donaldson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of disease: Cystic fibrosis
SM Rowe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies
I Carvalho-Oliveira et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1β in human bronchial epithelia
T Gray et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Regulation of antiprotease and antimicrobial protein secretion by airway submucosal gland serous cells
NS Joo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands
NS Joo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3
M Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
J Wolter et al.
THORAX (2002)
Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial
R Suri et al.
LANCET (2001)
Rethinking cystic fibrosis pathology: The critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation
VM Hudson
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Share Paper
